Related Experiment Video
Updated: Jun 27, 2026

Quantification of Autoreactive Antibodies in Mice upon Experimental Autoimmune Encephalomyelitis
Published on: December 1, 2023
Infectious Agents in Multiple Sclerosis: Viral Triggers, Antibody-Mediated Autoimmunity, and Parasitic
Dafni F T Frohman1, Stella E Tsirka2
1Department of Neurology, Mount Sinai Morningside/West, New York, NY 10019, USA.
Abstract:
Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system characterized by demyelination, neuroinflammation, and progressive neurodegeneration. While there is a small component of genetic susceptibility to MS risk, environmental factors, including infectious exposures, are gaining increased recognition as playing a critical role in MS initiation and progression. Viral infections, especially by Epstein-Barr virus (EBV), have emerged as strong candidates and triggers of MS symptoms, through antibody-mediated molecular mimicry and B-cell dysregulation. In contrast, parasitic infections, including helminths and select protozoa, appear to exert neuroprotective effects by skewing immune responses toward regulation and tolerance. In this review, we examine antibody-driven mechanisms by which viral pathogens promote autoimmunity in MS and contrast these with parasite-induced immunoregulatory pathways that suppress pathogenic inflammation. We further discuss diagnostic and therapeutic implications, highlighting how insights from infectious immunology may inform novel strategies for MS treatment.
Insights
Viral infections like Epstein-Barr virus may trigger multiple sclerosis (MS) through immune responses. Conversely, parasitic infections show potential neuroprotective effects, offering new avenues for MS treatment strategies.
Area of Science:
- Neuroimmunology
- Infectious Immunology
- Central Nervous System Disorders
Background:
- Multiple sclerosis (MS) is a chronic immune-mediated central nervous system disease.
- Environmental factors, particularly infections, are increasingly recognized as key players in MS.
- Epstein-Barr virus (EBV) is implicated in MS pathogenesis via molecular mimicry and B-cell issues.
Purpose of the Study:
- To review antibody-driven mechanisms of viral-induced autoimmunity in MS.
- To contrast these with parasite-induced immunoregulatory pathways.
- To explore diagnostic and therapeutic implications for MS treatment.
Main Methods:
- Review of scientific literature on infectious agents and MS.
- Analysis of immune mechanisms involved in viral and parasitic infections.
- Examination of antibody-mediated autoimmunity and immune tolerance.
Main Results:
- Viral infections, notably EBV, can promote MS autoimmunity through specific immune responses.
- Parasitic infections demonstrate neuroprotective potential by inducing immune tolerance.
- Contrasting these pathogen-host interactions offers insights into MS pathogenesis.
Conclusions:
- Understanding infectious triggers and protective mechanisms is crucial for MS.
- Novel therapeutic strategies for MS may emerge from studying host-pathogen immune interactions.
- Targeting immune pathways informed by infectious immunology holds promise for MS treatment.
More Related Videos
Related Concept Videos
Multiple Sclerosis l: Introduction
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Encephalitis ll: Pathophysiology
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Encephalitis l: Introduction
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

